Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

ClinicalTrials.gov ID: NCT06742957

Public ClinicalTrials.gov record NCT06742957. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site, Clinical Study to Evaluate the Therapeutic Equivalence of Tapinarof Cream 1% (Teva Pharmaceuticals, Inc.) With VTAMA® Tapinarof (Tapinarof) Cream 1% (Dermavant Sciences, Inc.) in Adult Patients With Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA® (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.

Study identification

NCT ID
NCT06742957
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
560 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2024 (Actual)
Primary completion
Oct 7, 2025 (Actual)
Completion
Nov 12, 2025 (Actual)
Last update posted
Dec 17, 2025

2024 – 2025

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Site 12107 Scottsdale Arizona 85260 —
Site 12101 Bryant Arkansas 72022 —
Site 12110 Dublin California 94568 —
Site 12112 Dublin California 94568 —
Site 12102 Fremont California 94538 —
Site 12119 Huntington Beach California 92647 —
Site 12120 Northridge California 91325 —
Site 12111 Pomona California 91767 —
Site 12122 Greenwich Connecticut 06831 —
Site 12115 Fort Lauderdale Florida 33308 —
Site 12104 Miami Florida 33144 —
Site 12116 Miami Florida 33146 —
Site 12113 Miami Florida 33175 —
Site 12114 Miramar Florida 33027 —
Site 12108 Chicago Illinois 60614 —
Site 12121 Rolling Meadows Illinois 60008 —
Site 12106 Clarksville Indiana 47129 —
Site 12123 Merrillville Indiana 46410 —
Site 12105 Louisville Kentucky 40241 —
Site 12109 Las Vegas Nevada 89121 —
12127 Woodbury New York 11797 —
Site 12126 Portland Oregon 97210 —
Site 12125 Upper Saint Clair Pennsylvania 15241 —
Site 12103 College Station Texas 77845 —
Site 12118 El Paso Texas 79925 —
Site 12117 Houston Texas 77070 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06742957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06742957 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →